<DOC>
	<DOCNO>NCT01149837</DOCNO>
	<brief_summary>The InnoLIA HTLV I/II Score vitro diagnostic test confirmation antibody human T-cell lymphotropic virus ( HTLV ) type I type II human blood sample . It intend supplemental test blood donor sample reactive routine anti-HTLV screening test . This study determine test useful donor counseling purpose .</brief_summary>
	<brief_title>Evaluation InnoLIA HTLV I/II Score</brief_title>
	<detailed_description>The InnoLIA HTLV I/II Score study consist three sub-studies . The first sub-study determine sensitivity , specificity accuracy HTLV type assignment use well-characterized sample NIH-funded HTLV Outcomes Study ( HOST ) . The second sub-study compare automate read interpretation test result manual read interpretation use sub-set sample test initial study . The third sub-study allows use InnoLIA HTLV I/II Score supplemental test whole blood HCT/P donor test repeatedly reactive FDA-approved donor screen test anti-HTLV-I/II .</detailed_description>
	<criteria>Subjects complete health history evaluation routine donor screen Subjects willing able provide inform consent Subjects test repeat reactive license screen test HTLV antibodies Subjects meet health history criterion routine donor screening Subjects unwilling unable provide inform consent Subjects test negative license screen test HTLV antibody</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>HTLV</keyword>
	<keyword>HTLV I</keyword>
	<keyword>HTLV II</keyword>
	<keyword>HTLV Type I and/or HTLV Type II antibody</keyword>
</DOC>